Sage Journals: Discover world-class research

Retricted access

Research article

First published 2002-7

Anakinra Treatment of Patients with Rheumatoid Arthritis

Leonard H Calabrese

Annals of Pharmacotherapy

Retricted access

Research article

First published 2020-6

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study

Massimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari [...]

European Journal of Preventive Cardiology

Retricted access

Research article

First published 2020-12

Efficacy of anakinra for idiopathic and non-idiopathic pericarditis refractory or intolerant to conventional therapy

Muhammad HS Shaukat, Sukhraj Singh, Kathryn Davis [...]

European Heart Journal: Acute Cardiovascular Care

Free access

Letter

First published 2010-4

Successful Treatment of Schnitzler's Syndrome with Anakinra after Failure of Rituximab Trial

N. Cascavilla, M. Bisceglia, G. D'Arena

International Journal of Immunopathology and Pharmacology

Free access

Research article

First published 2014-10

Anakinra and Tocilizumab Enhance Survival and Function of Human Islets during Culture: Implications for Clinical Islet Transplantation

Afaf Sahraoui, Kristine Kloster-Jensen, Thor Ueland [...]

Cell Transplantation

Open access

Case report

First published 2023

Efficacy of Anakinra Treatment in two Moroccan Patients With Mevalonate Kinase Deficiency

Manal Souali, Asmaa Sakhi, Ahmed Aziz Bousfiha [...]

Sage Open Pediatrics

Open access

Research article

First published 2023-8

Use of Intravenous Anakinra for Management of Pediatric Cytokine Storm Syndromes at an Academic Medical Center

Lirong Yang, Sandra Lowry, Travis Heath

Hospital Pharmacy

Open access

Brief report

First published 2024

Improved survival outcomes with anakinra over etoposide-based therapies for the management of adults with hemophagocytic lymphohistiocytosis: a retrospective multicenter research network study

Benjamin J. Lee

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2019-9

Interleukin 1 Receptor Antagonist Anakinra,Intravenous Immunoglobulin,and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis

Philipp Wohlfarth, Hermine Agis, Guido A. Gualdoni [...]

Journal of Intensive Care Medicine

Open access

Case report

First published 2020

Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still’s disease: when dosage matters in overcoming secondary therapy resistance

Sofia Ajeganova, Ann De Becker, Rik Schots

Therapeutic Advances in Musculoskeletal Disease

Search results